Provided by Tiger Trade Technology Pte. Ltd.

Goldman Sachs Holdings

2,404.33
+15.330.64%
Number of Gainers:64
Number of Losers:33
Number of Flat:- -
PE:- -
High:2,408.31
Open:2,388.89
Low:2,388.63
Close:2,389.08
Volume:698.78M
Turnover:154.32B
Market Cap:53.26T
Float Cap:49.89T

Loading ...

Tesla (TSLA.US) Secures $30 Billion in Backup Credit as FSD Experience Leaps Forward and Optimus Humanoid Robot Races Toward Mass Production, Accelerating Musk's "Physical AI Super Ambition"

Stock News
·
Sep 30

Disney Reportedly Cuts Hundreds of Jobs in HR and Technology Divisions

Deep News
·
Sep 30

Tesla Lines up $30 Billion Credit Lines as Capex, AI Push Accelerate

Reuters
·
Sep 30

Why Kroger is Trying to be More Like Walmart

Dow Jones
·
Sep 30

US Consumer Sentiment Plummets to Lowest Since 2014 as Spending Intentions Broadly Cool, Putting Fed in a Policy Bind

Deep News
·
Sep 30

AJ Lucas Sets November Date for 2026 AGM and Director Nominations

TIPRANKS
·
Sep 30

Overnight News for September 30: U.S. Stocks Close Lower, Oil Slips, Gold Rebounds; Fed's Williams Says No Rush to Act After September Rate Hike

Deep News
·
Sep 30

Trump Defends Light-Touch AI Strategy After Industry Sounds Alarms

Dow Jones
·
Sep 30

Fed Officials Push Hawkish Message: Williams Sees Possible One More Hike This Year, Goolsbee Warns Inflation Above Target Is "Playing with Fire"

Stock News
·
Sep 30

Trump Unveils AI-Powered America.gov Portal, Meets Industry Leaders; OpenAI Launches Always-On Assistant Dots; Apple's New CEO Pursues Internal Overhaul

Deep News
·
Sep 30

US Stocks Overnight: 30-Year Treasury Yield Rises for Sixth Straight Session, Major Indexes Close Lower, Meta (META.US) Gains Over 3%

Stock News
·
Sep 30

Eli Lilly reports results from TRIUMPH-2 Phase 3 trial

TIPRANKS
·
Sep 30

Lilly's Experimental Drug Cuts Weight by 21% in Diabetes Trial

Reuters
·
Sep 30

Top 20 US Stock Trades by Volume on September 30: Micron Gains Over 1%, Q4 Earnings Due After Wednesday's Close

Deep News
·
Sep 30

Eli Lilly - Retatrutide 12 Mg Results in 49.6 Lb (20.8%) Weight Loss over 80 Weeks

THOMSON REUTERS
·
Sep 30

Lilly's Triple Agonist, Retatrutide, Delivered Substantial Weight Loss and A1c Reduction, Underscoring Its Potential Promise for People with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Sep 30

Eli Lilly - to Submit Biologics License Application for Retatrutide in Q1 2027

THOMSON REUTERS
·
Sep 30

Eli Lilly - 59.5% of Retatrutide 12 Mg Participants no Longer Meet Bmi Criteria for Obesity

THOMSON REUTERS
·
Sep 30

Anthropic routed 47% of last year’s sales through Amazon, Google, Reuters says

TIPRANKS
·
Sep 30

S&P Global Inc.: Qtrly Dividend of $0.97 Per Share is Payable on December 10

THOMSON REUTERS
·
Sep 30